Jan. 11, 2024
by Michael Whitworth, Trevor Hutchings, Alex Jones
Biopharma insight
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. …
Jan. 11, 2024
by Andrii Buvailo
Interview
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
Jan. 9, 2024
by Andrii Buvailo
Biopharma insight
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
Jan. 7, 2024
by Dana Sokolova
Biopharma insight
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Jan. 5, 2024
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Nov. 27, 2023
by Andrii Buvailo
Biopharma insight
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Nov. 17, 2023
by Andrii Buvailo
Biopharma insight
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Nov. 7, 2023
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Nov. 3, 2018
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …